Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01959867 | SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy | withdrawn | N/A | 0 | Integra LifeSciences CorporationINDUSTRY | 0 | Jan 10, 2017 | clinicaltrials |
| NCT02661100 | A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients | withdrawn | Phase 1 / Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Dec 7, 2016 | clinicaltrials |
| NCT00450515 | Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer | withdrawn | Phase 2 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Dec 6, 2016 | clinicaltrials |
| NCT02058667 | Reirradiation With Concurrent Paclitaxel for Breast Cancer | withdrawn | Phase 1 | 0 | University of KentuckyOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT02759549 | Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH | withdrawn | N/A | 0 | Emory UniversityOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT00774241 | PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer | withdrawn | Phase 4 | 0 | Hoffmann-La RocheINDUSTRY | 0 | Nov 2, 2016 | clinicaltrials |
| NCT01156961 | A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX) | withdrawn | Phase 4 | 0 | Hoffmann-La RocheINDUSTRY | 0 | Nov 2, 2016 | clinicaltrials |
| NCT01943240 | Pectoral Nerve Blockade in Mastectomy | withdrawn | Phase 4 | 0 | Timothy R PetersenOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT01479179 | Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 26, 2016 | clinicaltrials |
| NCT01756092 | Treatment of Benign Breast Deformities and Post-Segmental Mastectomy Breast Deformities With Autologous Fat Grafting (AFT) | withdrawn | N/A | 0 | University of PittsburghOTHER | 1 | Oct 21, 2016 | clinicaltrials |
| NCT02610621 | Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy | withdrawn | Phase 2 | 0 | Cedars-Sinai Medical CenterOTHER | 1 | Oct 13, 2016 | clinicaltrials |
| NCT02725541 | Trial of Neoadjuvant Trastuzumab Emtansine in Patients With HER2-Equivocal Breast Cancer(NATURE) | withdrawn | Phase 2 | 0 | Jenny C. Chang, MDOTHER | 1 | Sep 14, 2016 | clinicaltrials |
| NCT02102438 | Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer | withdrawn | N/A | 0 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Aug 31, 2016 | clinicaltrials |
| NCT00692458 | A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029) | withdrawn | Phase 3 | 0 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 12, 2016 | clinicaltrials |
| NCT02183597 | Whole-body MRI for the Detection of Metastasis(WBMRI) | withdrawn | — | 0 | Norwegian University of Science and TechnologyOTHER | 0 | Aug 10, 2016 | clinicaltrials |
| NCT02539017 | The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer | withdrawn | Phase 2 | 0 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02639611 | Effectiveness of Acupuncture in Post-Mastectomy Patients With Tissue Expanders | withdrawn | N/A | 0 | NYU Langone HealthOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT02429544 | Effects of a Group Residential Retreat on Cancer Outcomes | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Aug 1, 2016 | clinicaltrials |
| NCT02627430 | Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Jul 26, 2016 | clinicaltrials |
| NCT01360177 | Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers | withdrawn | N/A | 0 | Stanford UniversityOTHER | 1 | Jul 20, 2016 | clinicaltrials |
| NCT00041171 | Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT00053339 | Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT02637375 | A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer | withdrawn | N/A | 0 | University of ChicagoOTHER | 0 | May 30, 2016 | clinicaltrials |
| NCT01016028 | Chemotherapy-Induced Peripheral Neuropathy Survey | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | May 3, 2016 | clinicaltrials |
| NCT02338531 | Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer(RHEA) | withdrawn | Phase 2 | 0 | Jules Bordet InstituteOTHER | 2 | Apr 29, 2016 | clinicaltrials |
| NCT02215876 | Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer | withdrawn | Phase 2 | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT00123812 | Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy | withdrawn | — | 0 | AHS Cancer Control AlbertaOTHER | 0 | Feb 24, 2016 | clinicaltrials |
| NCT01302002 | The Use of Metformin in Early Breast Cancer Patients Pre-Surgery | withdrawn | Early Phase 1 | 0 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Feb 23, 2016 | clinicaltrials |
| NCT01410708 | TORI 104 Pre-Surgical Dasatinib | withdrawn | Phase 2 | 0 | AHS Cancer Control AlbertaOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT01593384 | Prospective Chart-Review: Impact of Combination - Digital Breast Tomosynthesis + Digital Mammography | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Feb 17, 2016 | clinicaltrials |
| NCT00580021 | Clinical Outcomes in Hereditary Cancer | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT02539615 | A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old | withdrawn | Phase 3 | 0 | Atossa Therapeutics, Inc.INDUSTRY | 1 | Jan 25, 2016 | clinicaltrials |
| NCT01985893 | Safety and Efficacy of Lapatinib Plus Trastuzumab or Lapatinib Plus Capecitabine in Metastatic Breast Cancer(THOR) | withdrawn | Phase 2 | 0 | Berufsverband Niedergelassener Gynäkologischer Onkologen in Deutschland e.V.OTHER | 1 | Jan 14, 2016 | clinicaltrials |
| NCT00978276 | Immunohistochemical (IHC) Scoring for Receptors Expression in Breast Tissues | withdrawn | — | 0 | Applied Spectral Imaging Ltd.INDUSTRY | 0 | Jan 5, 2016 | clinicaltrials |
| NCT00343759 | Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy | withdrawn | Phase 2 | 0 | University of PennsylvaniaOTHER | 1 | Dec 11, 2015 | clinicaltrials |
| NCT00006126 | Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery | withdrawn | Phase 1 | 0 | Northwestern UniversityOTHER | 0 | Nov 13, 2015 | clinicaltrials |
| NCT01542216 | Evaluation of Nutrition and Metabolism in Breast Cancer Patients | withdrawn | N/A | 0 | University of WaterlooOTHER | 1 | Nov 5, 2015 | clinicaltrials |
| NCT02526719 | Nipple Delay Prior to Nipple Sparing Mastectomy: A Pilot RCT | withdrawn | N/A | 0 | University Health Network, TorontoOTHER | 0 | Nov 2, 2015 | clinicaltrials |
| NCT02525913 | Feasibility Study of Cavity Radiofrequency Ablation in ex Vivo Mastectomy Breast Tissue | withdrawn | N/A | 0 | University of ArkansasOTHER | 1 | Oct 12, 2015 | clinicaltrials |
| NCT00075413 | Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer | withdrawn | Phase 2 | 0 | The University of Texas Medical Branch, GalvestonOTHER | 0 | Oct 2, 2015 | clinicaltrials |
| NCT00530751 | Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Oct 2, 2015 | clinicaltrials |
| NCT00898573 | Lapatinib Resistance in Patients With Breast Cancer | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Oct 2, 2015 | clinicaltrials |
| NCT00364975 | Development of Gourmet Healthy Cooking Workshop for Cancer Patients | withdrawn | N/A | 0 | Hadassah Medical OrganizationOTHER | 1 | Sep 22, 2015 | clinicaltrials |
| NCT01501604 | BKM120 in Cancers With PIK3CA Activating Mutations | withdrawn | Phase 2 | 0 | Massachusetts General HospitalOTHER | 0 | Sep 17, 2015 | clinicaltrials |
| NCT02053597 | TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen(TRIUMPH) | withdrawn | Phase 2 | 0 | Jules Bordet InstituteOTHER | 1 | Sep 17, 2015 | clinicaltrials |
| NCT02396433 | Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers | withdrawn | Phase 1 / Phase 2 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 0 | Aug 25, 2015 | clinicaltrials |
| NCT00704392 | Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors | withdrawn | Phase 1 | 0 | ExelixisINDUSTRY | 1 | Aug 20, 2015 | clinicaltrials |
| NCT02111031 | Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients | withdrawn | — | 0 | Janssen Diagnostics, LLCINDUSTRY | 1 | Jun 19, 2015 | clinicaltrials |
| NCT00899639 | Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer | withdrawn | — | 0 | Rutgers, The State University of New JerseyOTHER | 0 | May 29, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Jan 10, 2017source: clinicaltrials